Mair Therapeutics

Mair Therapeutics

This biotechnology company develops small-molecule therapeutics targeting lysosomal ion channels for patients with neurodegenerative conditions such as Parkinson’s disease.

Lysosomal Therapeutics

This biotechnology firm develops small-molecule therapies for patients with neurodegenerative conditions such as Parkinson's disease and other lysosomal storage disorders.

Mitokinin

This biotechnology company develops small molecule drugs to treat Parkinson's disease and other neurodegenerative conditions for patients and healthcare providers.

NeurOdys Therapeutics

This biotechnology company develops small molecule therapies for neurodegenerative disorders including Alzheimer's and Parkinson's diseases for healthcare providers and patients.

Muna Therapeutics

This biopharmaceutical company develops small-molecule therapeutics to treat neurodegenerative diseases, such as Alzheimer's and Parkinson's, for patients and healthcare providers.

NeurOdys Therapeutics

This biotechnology company develops small molecule therapies for patients with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.

Amplify Therapeutics

This biopharmaceutical company develops disease-modifying therapies for lysosomal Parkinson's disease and Gaucher disease to treat patients with specific genetic subgroups.

Lyterian

This company develops small molecule therapeutics using protein homeostasis mechanisms to treat neurodegenerative and protein aggregation diseases for patients with unmet medical needs.